|
This Web site is a component of the SAMHSA Health Information Network.
|
|
The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers
Treatment Improvement Protocol (TIP) Series 18
- Duiona R.
Baker, M.P.H.
- Special Assistant for Alcohol and Other Drug Abuse and Infectious Disease Prevention
- Quality Assurance and Evaluation Branch
- Center for Substance Abuse Treatment
- Substance Abuse and Mental Health Services Administration
- Michael J.
Brennan, Ph.D.
- Chief, Laboratory of Mycobacteria
- Division of Bacterial Products
- Center for Biologics Evaluation and Research
- Food and Drug Administration
- James F.
Callahan, D.P.A.
- Executive Vice President and CEO
- American Society of Addiction Medicine
- Diane M.
Canova, J.D.
- Executive Director
- Therapeutic Communities of America
- Arlington, Virginia
- Michele Carter, Ph.D.
- Bioethics Consultant
- Substance Abuse and Mental Health Services Administration
- Scott Clay
- Manager
- Infectious Disease National Programs
- American Lung Association
- Lenora S.
Colbert
- Vice President and Director
- Local 1199
- Occupational Safety and Health Department
- New York, New York
- Al DeMaria, M.D.
- Associate Commissioner and Public Health State Epidemiologist
- Massachusetts Department of Public Health
- Melanie Duckworth, M.S.W.
- Public Health Analyst
- Division of STD/HIV Prevention
- National Center for Prevention Services
- Centers for Disease Control and Prevention
- Sue C.
Etkind
- Director, Tuberculosis Program
- Massachusetts Department of Public Health
- June S.
Ewing, M.S.
- Review Policy Analyst
- Office of Extramural Programs
- Substance Abuse and Mental Health Services Administration
- John D.
Foulds, Ph.D.
- Tuberculosis Program Officer
- Respiratory Diseases Branch
- Division of Microbiology and Infectious Diseases
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Paul A.
Gaist, M.P.H.
- Senior Advisor
- Office of AIDS Research
- U.S.
Department of Health and Human Services
- National Institutes of Health
- Joel Goldstein, Ph.D.
- Deputy Director
- Office of Extramural Programs
- Substance Abuse and Mental Health Services Administration
- Harry W.
Haverkos, M.D.
- Acting Director
- Division of Clinical Research
- National Institute on Drug Abuse
- National Institutes of Health
- Edward T.
Morgan
- Acting Chief
- Human Resources Development
- Office for Scientific Analysis and Evaluation
- Center for Substance Abuse Treatment
- David H.
Mulligan
- Commissioner
- Massachusetts Department of Public Health
- Executive Office of Health and Human Services
- John W.
Poundstone, M.D., M.P.H.
- Commissioner of Health
- American Association of Public Health Physicians
- Lexington Fayette County Health Department
- Lexington, Kentucky
- Gary A.
Roselle, M.D.
- Program Director for Infectious Disease
- Department of Veterans Affairs Medical Center
- University of Cincinnati College of Medicine
- Margaret Salinger, M.S.N., R.N., C.A.R.N.
- Head Nurse/Supervisor
- Substance Abuse Treatment Unit
- National Nurses Society on Addictions
- Coatesville Veterans Medical Center
- Audubon, Pennsylvania
- John J.
Seggerson
- Chief of the Programs Services Branch
- Division of Tuberculosis Elimination
- Centers for Disease Control and Prevention
- Donald Storms, C.A.C, C.D.A.C.
- Chair, HIV/AIDS and Substance Abuse Committee
- National Association of Alcoholism and Drug Abuse Counselors
- Alan I.
Trachtenberg, M.D., M.P.H.
- Medical Officer
- Science Policy and Analysis Branch
- National Institute on Drug Abuse
- Sylvia Trent-Adams, R.N.
- Public Health Analyst
- Division of Programs for Special Populations
- Bureau of Primary Health Care
- Health Resources and Services Administration
- Karen S.
Wagner, J.D.
- Office of the General Counsel
- Department of Health and Human Services
- Brian M.
Willis, J.D., M.P.H.
- Attorney Advisor
- Office of the General Counsel
- Centers for Disease Control and Prevention
- Edward L.
Zuroweste, M.D.
- Medical Director
- Keystone Migrant Health
|
|
|
| |